Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,780,000
-11,000 (-0.61%)
Last updated: Jan 29, 2026, 2:10 PM KST
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 82.91 trillion as of January 29, 2026. Its market cap has increased by 21.21% in one year.
Market Cap
82.91T
Enterprise Value
82.37T
Revenue
4.56T
Ranking
n/a
PE Ratio
51.37
Stock Price
1,780,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 82.91T, an increase of 770.16%. That is a compound annual growth rate of 26.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 82.91T | 5.66% |
| Dec 30, 2025 | 78.46T | 16.17% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 47.04T |
| ALTEOGEN | 21.71T |
| SK Biopharmaceuticals | 9.45T |
| HLB Co., Ltd. | 8.38T |
| LigaChem Biosciences | 6.76T |
| Peptron | 6.53T |
| PharmaResearch | 5.21T |
| D&D Pharmatech | 4.21T |